Gourgoulianis K I, Lavdas E, Mizios P
Medical School University of Thessaly, General Hospital of Larissa, Greece.
Respiration. 1994;61(4):204-6. doi: 10.1159/000196338.
With the purpose of estimating the use of bronchodilators in asthma management as prescribed by primary health physicians (PHCP) in Greece, 62 PHCP answered a questionnaire about the manner of choice of treatment, the person who trained the patients in the use of inhalers, and the pharmacological treatment. 65% of PHCP selected the treatment according to the pulmonologist's recommendations and 34% by themselves. 26% of the PHCP trained their patients in the use of inhalers, and 40% considered that it was done by another physician. Forty-three physicians used adrenergic inhalers as the first choice of medicine. The second most popular medicine in asthma management is theophylline tablets (15% of all medicines). Consequently, PHCP in Greece frequently select asthma treatment according to the pulmonologist's recommendations, and consider that another physician has trained the patients how to use the inhalers. They frequently prescribe adrenergic inhalers, theophylline tablets and corticosteroid inhalers.
为了评估希腊基层医疗医生(PHCP)在哮喘管理中按照处方使用支气管扩张剂的情况,62名基层医疗医生回答了一份关于治疗选择方式、培训患者使用吸入器的人员以及药物治疗的问卷。65%的基层医疗医生根据肺科医生的建议选择治疗方法,34%由他们自己选择。26%的基层医疗医生培训患者使用吸入器,40%的人认为这是由另一名医生完成的。43名医生将肾上腺素能吸入器作为首选药物。哮喘管理中第二受欢迎的药物是茶碱片(占所有药物的15%)。因此,希腊的基层医疗医生经常根据肺科医生的建议选择哮喘治疗方法,并认为是另一名医生培训了患者如何使用吸入器。他们经常开肾上腺素能吸入器、茶碱片和皮质类固醇吸入器。